Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Chu et al. conducted a network meta-analysis to evaluate the efficacy and safety of Anti-integrins / Integrin inhibitors for treating Ulcerative colitis (UC). Vedolizumab was found to have the highest efficacy in maintaining clinical remission. However, these drugs are costly and come with numerous adverse effects, making them unaffordable for everyone.
see also:
[Anti-integrins / Integrin inhibitors & Inflammatory Bowel Disease (IBD)](brain://J85OhJyLqUmwpXMsM2EN1g/Ant…